How Does Mistletoe Therapy Work? – ABNOBA India

 Mistletoe therapy, widely used in integrative oncology, has gained attention for its potential to support cancer patients alongside conventional treatments. Developed through rigorous research in Germany by ABNOBA GmbH, this therapy involves extracts from the mistletoe plant (Viscum album), which are administered through subcutaneous injections.

So, how does mistletoe therapy work?

Mistletoe extract contains biologically active compounds such as lectins, viscotoxins, and polysaccharides. These compounds are known to stimulate the immune system by enhancing the activity of white blood cells and natural killer cells—key components in the body’s defense against cancer. This immune activation can help the body recognize and fight tumor cells more effectively.

In addition to immune support, mistletoe therapy is noted for improving the quality of life in cancer patients. Many recipients report better energy levels, reduced fatigue, less nausea, and improved appetite during chemotherapy or radiation. It also promotes emotional well-being, reducing anxiety and depression associated with cancer treatment.

ABNOBA mistletoe extracts are manufactured using pharmaceutical-grade quality standards, ensuring consistency, safety, and effectiveness. Each product is tailored based on the host tree, preparation method, and therapeutic indications, allowing physicians to personalize treatment for individual patients.

In India, ABNOBA India makes this innovative therapy available to patients seeking integrative oncology care. Mistletoe therapy is not a standalone cure but an evidence-based complementary treatment aimed at enhancing overall health outcomes for cancer patients.

For more information, visit: www.abnoba.in





Comments

Post a Comment

Popular posts from this blog

Exploring the Healing Potential of Mistletoe Therapy in Cancer Care

Image
 Mistletoe therapy, long integrated into European oncology practices, is gaining global recognition for its ability to enhance the overall well-being of cancer patients. Manufactured by ABNOBA GmbH , a leading German research-based pharmaceutical company, mistletoe extracts are now accessible in India through ABNOBA India , bringing a powerful complementary approach to supportive cancer care. Unlike conventional treatments that directly target tumors, mistletoe therapy works by stimulating the body’s own defenses . Its active ingredients, including mistletoe lectins , help activate immune cells and regulate the immune response—crucial during cancer treatment, when immunity is often compromised. One of mistletoe therapy’s most appreciated benefits is its impact on quality of life . Clinical studies have shown that patients receiving mistletoe extracts often report reduced treatment-related fatigue , nausea , and emotional distress , leading to better energy levels and a more stabl...
Read more

Unlocking the Healing Potential of Mistletoe Extracts in Modern Medicine

Image
Mistletoe ( Viscum album ) is more than just a symbol of tradition—it holds immense therapeutic promise in the field of integrative oncology. For decades, mistletoe extracts have been utilized in Europe, particularly in German-speaking countries, as a supportive treatment for cancer patients. Their role in enhancing immune function, improving tolerance to chemotherapy, and increasing overall well-being is well documented through scientific and clinical research. ABNOBA GmbH , a reputable German pharmaceutical company based in Pforzheim, is a pioneer in the development and production of standardized mistletoe extracts. With a commitment to scientific rigor and patient safety, ABNOBA ensures that its products maintain high levels of purity, consistency, and efficacy. Through ABNOBA India, these advanced therapies are now accessible to a wider patient base in South Asia, bridging the gap between traditional European therapies and modern Indian medical practices. The therapeutic compoun...
Read more

Scientific Evidence Supporting Mistletoe Therapy in Oncology

Image
Mistletoe therapy, derived from the European mistletoe plant ( Viscum album ), has gained attention as a complementary treatment in oncology, particularly in German-speaking countries. ABNOBA GmbH, a research-driven pharmaceutical company based in Pforzheim, Germany, has been at the forefront of developing standardized mistletoe extracts used in integrative cancer care. Scientific investigations over the past few decades have supported the potential benefits of mistletoe therapy in cancer treatment . Preclinical studies indicate that mistletoe extracts possess immunomodulatory, apoptotic (cell death-inducing), and cytotoxic effects against various tumor cell lines. These properties are largely attributed to mistletoe lectins and viscotoxins, key bioactive compounds in the extract. Clinical research, including randomized controlled trials, has shown that mistletoe therapy can improve quality of life, reduce chemotherapy side effects such as fatigue and nausea, and possibly extend surv...
Read more